Clinical trial
MASCOT: Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With…
NCT00263055 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00263055 |
|---|---|
| Title | MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV |
| Official title | Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Colonic Neoplasms |
| Intervention type | Drug |
| Interventions | oxaliplatin |
| Start date | Aug 1, 2004 |
| Primary completion | Jun 1, 2005 |
| First posted | Dec 7, 2005 |
| Last update posted | Sep 15, 2009 |
| Countries | China, Hong Kong, South Korea, Taiwan, Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: